NCT00304993View on ClinicalTrials.gov

Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2001

Study Completion Date

February 28, 2005

Conditions
Metabolic Syndrome XInsulin Resistance
Interventions
DRUG

fenofibrate

DRUG

niacin

DRUG

rosiglitazone

Trial Locations (1)

33705

Foundation Research, St. Petersburg

Sponsors
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

collaborator

Kos Pharmaceuticals

INDUSTRY

collaborator

Abbott

INDUSTRY

lead

Foundation Research, Florida

OTHER